Results 111 to 120 of about 32,650 (235)
Journal of Applied Clinical Medical Physics, Volume 27, Issue 2, February 2026.Abstract Background Helical TomoTherapy provides highly conformal dose distributions for breast irradiation but is limited by extensive low‐dose spillage (“low‐dose bath”), contributing to increased integral dose and potential long‐term toxicities. Complete blocks can suppress low‐dose spread, but at the cost of prolonged treatment times on legacy ...
Chih‐Chieh Chang +2 more
wiley +1 more source
Siriraj Medical Journal, 2020 A hemorrhagic breast mass was excised from a 27-year-old female. Microscopically, the tumor showed typical areas of invasive ductal carcinoma with intraductal component admixed with some trophoblast-like tumor giant cells in the hemorrhagic area.
Piyavadee Leksrisakul +6 more
doaj
Journal of Applied Clinical Medical Physics, Volume 27, Issue 2, February 2026.Abstract Background Using a constant relative biological effectiveness (RBE = 1.1) in proton therapy may underestimate the RBE‐weighted dose in high linear energy transfer (LET) regions at the distal end of the beam, thereby limiting the ability to accurately predict clinical outcomes.
Zhen Cao, Qing Zhang, Jingfang Zhao
wiley +1 more source
Revista de Ciencias Médicas de Pinar del Río, 2005 Se realizó un estudio retrospectivo y comparativo tomando como universo 530 pacientes portadoras de cáncer de mama en las etapas I y II de la enfermedad, operadas en el servicio de Cirugía General del Hospital Clínico Quirúrgico "Abel Santamaría Cuadrado"
Gilberto Cabrera Nogueira +2 more
doaj
Breast Events After Treatment of Ductal Carcinoma In Situ in Women: A Population‐Based Study
Cancer Medicine, Volume 15, Issue 2, February 2026.ABSTRACT Background Despite favourable survival prognosis, the main concern for ductal carcinoma in situ (DCIS) is local recurrence, especially progression to invasive cancer. This study identified factors associated with breast events following DCIS treatment.
Qian Chen +5 more
wiley +1 more source
Novel schedule for treatment of inflammatory breast cancer [PDF]
, 2016 Inflammatory breast cancer (IBC) is the most aggressive form of this tumor, with the clinical and biological characteristics of a rapidly proliferating disease.
Cefalì, K +5 more
core
Prognosis of Metaplastic Breast Cancer: A Population‐Based Matched Cohort Study
Cancer Medicine, Volume 15, Issue 2, February 2026.ABSTRACT Purpose Metaplastic breast cancer (metBC) is a rare subtype of breast cancer known for its challenging management. The impact of this histological subtype on prognosis remains unclear. Methods Data were collected from the Swedish Cancer Registry between 2008 and 2018.
Marie Bergman +6 more
wiley +1 more source
Metformin‐Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention
Cancer Medicine, Volume 15, Issue 2, February 2026.Metformin (MET), a common antihyperglycemic drug, shows promising anti‐cancer effects in breast cancer (BC). It activates adenosine monophosphate‐activated protein kinase (AMPK), regulating cellular energy and inducing cell cycle arrest, anti‐proliferation, and microenvironment alterations.
Ambulugala Gamage Rajika Greshamali Jinadasa +4 more
wiley +1 more source
Pleural Metastasis From Male Breast Cancer: A Case Report
Diagnostic Cytopathology, Volume 54, Issue 2, Page E36-E39, February 2026.ABSTRACT Male breast cancer (MBC) is a rare disease accounting for less than 1% of breast cancers and for 0.11% of all male malignancies. Despite the fact that the epidemiologic, clinical, and therapeutic literature regarding female breast cancer is well documented, little is known about the features of male breast cancer.
Patrizia Straccia, Esther Diana Rossi
wiley +1 more source